We are live on
!
Find out more
ML
McAdam LLC Portfolio holdings
AUM
$2.59B
1-Year Est. Return
21.24%
This Fund
S&P 500
This Quarter
Est. Return
+1.6%
1 Year Est. Return
+21.24%
3 Year Est. Return
+57.44%
5 Year Est. Return
+51.44%
10 Year Est. Return
–
AUM
$246M
AUM Growth
+$27.9M
(+13%)
Cap. Flow
+$24.9M
Cap. Flow
% of AUM
10.14%
Top 10 Holdings %
Top 10 Hldgs %
64.81%
Holding
904
New
61
Increased
149
Reduced
132
Closed
202
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
+$2.75M |
| 2 |
Schwab US Large- Cap ETF
SCHX
|
+$2.47M |
| 3 |
Schwab US Aggregate Bond ETF
SCHZ
|
+$2.28M |
| 4 |
Schwab International Equity ETF
SCHF
|
+$2M |
| 5 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$1.99M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$131K |
| 2 |
iShare MSCI Eurozone ETF
EZU
|
+$113K |
| 3 |
Vanguard Morningstar Growth ETF
VUG
|
+$104K |
| 4 |
Vanguard Total World Stock ETF
VT
|
+$103K |
| 5 |
Invesco S&P 500 Pure Value ETF
RPV
|
+$97.9K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 93.97% |
| 2 | Technology | 1.2% |
| 3 | Healthcare | 1.19% |
| 4 | Consumer Discretionary | 0.7% |
| 5 | Communication Services | 0.61% |
Similar funds
CF
PA
VWM
MFAM
MG
PI
BCF
FHC
McAdam LLC's Q2 2018 Portfolio in Review
As of Q2 2018, McAdam LLC held 904 positions worth $246M, up 13% from $218M the previous quarter. Its ten largest holdings account for 65% of the portfolio.
McAdam LLC deployed $24.9M of net new capital in Q2 2018, opening 61 new positions and adding to 149 existing holdings. Its largest new stake was BrightSpire Capital: 7,203 shares worth $149K.
By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, up from 93% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $131K trimmed.
- McAdam LLC's largest Q2 2018 buy was BrightSpire Capital: 7,203 shares worth $149K.
- McAdam LLC added most to Schwab Fundamental US Large Company Index ETF in Q2 2018, an estimated $2.75M increase.
- McAdam LLC's biggest Q2 2018 reduction was Vertex Pharmaceuticals, cutting an estimated $131K.
- McAdam LLC fully exited ProShares Short S&P500 in Q2 2018, selling an estimated $76K.
- McAdam LLC's ten largest holdings make up 65% of its $246M portfolio in Q2 2018.
- McAdam LLC opened 61 new positions and closed 202 in Q2 2018.
- McAdam LLC's portfolio value rose 13% quarter-over-quarter to $246M.
Based on McAdam LLC's 13F filing for Q2 2018, filed 22 Aug 2018.